Cardiff Oncology Inc (CRDF)

Official site

HEALTHCARE • BIOTECHNOLOGY • NASDAQ

$0.97

-0.00 (-0.25%)

Market Cap: $78.57M

Last updated: Oct 16, 2026 at 1:55 PM ET

Earnings

Performance (10Y)

Beat Rate

69%(27/39)

Avg Surprise

+6.14%

Streak

1 Q

Upcoming Estimates

Period ending Sep 30, 2026

EPS Consensus$-0.13

Range$-0.14 - $-0.12

4 analysts

EPS Revisions

30d

EPS Estimate DriftChange to current

90d ago$-0.17+22.8%

60d ago$-0.17+22.8%

30d ago$-0.130.0%

7d ago$-0.130.0%

Current$-0.13

Revenue Consensus

$86430

Range$0 - $150000

7 analysts

Period ending Dec 31, 2026

EPS Consensus$-0.15

Range$-0.19 - $-0.09

4 analysts

Revenue Consensus

$55380

Range$-239760 - $205240

7 analysts

Period	Reported	Est.	Range	Surprise	B/M	Analysts	Revisions	YoY
Dec 31, 2026Dec 26EST	-	$-0.15	$-0.19 - $-0.09	-	-	4	-	-
Sep 30, 2026Sep 26EST	-	$-0.13	$-0.14 - $-0.12	-	-	4	4 0 30d	-
Jun 30, 2026Jun 26 Reported Aug 11, 2026Reported Aug 11	$-0.14	$-0.17	$-0.15 - $-0.12	+17.65%	Beat	6	0 5 30d	+33.3%
Mar 31, 2026Mar 26 Reported May 14, 2026Reported May 14	$-0.18	$-0.12	$-0.16 - $-0.11	-50.00%	Miss	5	3 0 30d	+10.0%
Dec 31, 2025Dec 25 Reported Feb 24, 2026Reported Feb 24	$-0.11	$-0.20	$-0.26 - $-0.18	+45.00%	Beat	6	2 0 30d	+47.6%
Sep 30, 2025Sep 25 Reported Nov 6, 2025Reported Nov 6	$-0.17	$-0.21	$-0.23 - $-0.19	+19.05%	Beat	6	1 3 30d	+32.0%
Jun 30, 2025Jun 25 Reported Jul 29, 2025Reported Jul 29	$-0.21	$-0.20	$-0.22 - $-0.16	-5.00%	Miss	6	0 1 30d	+19.2%
Mar 31, 2025Mar 25 Reported May 8, 2025Reported May 8	$-0.20	$-0.19	$-0.23 - $-0.14	-5.26%	Miss	5	1 0 30d	+9.1%
Dec 31, 2024Dec 24 Reported Feb 27, 2025Reported Feb 27	$-0.21	$-0.25	$-0.29 - $-0.20	+15.15%	Beat	4	1 0 30d	+0.0%
Sep 30, 2024Sep 24 Reported Nov 7, 2024Reported Nov 7	$-0.25	$-0.27	$-0.29 - $-0.26	+7.41%	Beat	5	No revisions (30d)	-13.6%
Jun 30, 2024Jun 24 Reported Aug 8, 2024Reported Aug 8	$-0.26	$-0.25	$-0.25 - $-0.25	-4.00%	Miss	0	No revisions (30d)	-4.0%
Mar 31, 2024Mar 24 Reported May 2, 2024Reported May 2	$-0.22	$-0.25	$-0.27 - $-0.23	+12.00%	Beat	4	No revisions (30d)	+12.0%
Dec 31, 2023Dec 23 Reported Feb 29, 2024Reported Feb 29	$-0.21	$-0.28	$-0.29 - $-0.27	+25.00%	Beat	4	No revisions (30d)	-5.0%
Sep 30, 2023Sep 23 Reported Nov 2, 2023Reported Nov 2	$-0.22	$-0.29	$-0.32 - $-0.27	+24.14%	Beat	5	No revisions (30d)	-10.0%
Jun 30, 2023Jun 23 Reported Aug 9, 2023Reported Aug 9	$-0.25	$-0.25	$-0.29 - $-0.23	+0.00%	Beat	5	No revisions (30d)	-4.2%
Mar 31, 2023Mar 23 Reported May 4, 2023Reported May 4	$-0.25	$-0.22	$-0.25 - $-0.21	-13.64%	Miss	5	No revisions (30d)	+0.0%
Dec 31, 2022Dec 22 Reported Mar 2, 2023Reported Mar 2	$-0.20	$-0.23	$-0.30 - $-0.20	+13.04%	Beat	4	No revisions (30d)	+13.0%
Sep 30, 2022Sep 22 Reported Nov 3, 2022Reported Nov 3	$-0.20	$-0.24	$-0.29 - $-0.24	+16.67%	Beat	5	No revisions (30d)	-17.6%
Jun 30, 2022Jun 22 Reported Aug 4, 2022Reported Aug 4	$-0.24	$-0.25	$-0.25 - $-0.25	+4.00%	Beat	0	No revisions (30d)	-41.2%
Mar 31, 2022Mar 22 Reported May 5, 2022Reported May 5	$-0.25	$-0.23	$-0.25 - $-0.21	-8.70%	Miss	6	No revisions (30d)	-78.6%
Dec 31, 2021Dec 21 Reported Feb 24, 2022Reported Feb 24	$-0.23	$-0.17	$-0.19 - $-0.14	-35.29%	Miss	6	No revisions (30d)	-187.5%
Sep 30, 2021Sep 21 Reported Nov 4, 2021Reported Nov 4	$-0.17	$-0.17	$-0.19 - $-0.15	+0.00%	Beat	4	1 0 30d	+10.5%
Jun 30, 2021Jun 21 Reported Aug 5, 2021Reported Aug 5	$-0.17	$-0.15	$-0.17 - $-0.12	-13.33%	Miss	4	No revisions (30d)	+66.7%
Mar 31, 2021Mar 21 Reported May 6, 2021Reported May 6	$-0.14	$-0.15	$-0.17 - $-0.12	+6.67%	Beat	4	No revisions (30d)	+65.9%
Dec 31, 2020Dec 20 Reported Feb 25, 2021Reported Feb 25	$-0.08	$-0.14	$-0.15 - $-0.12	+42.86%	Beat	4	No revisions (30d)	+84.3%
Sep 30, 2020Sep 20 Reported Nov 5, 2020Reported Nov 5	$-0.19	$-0.19	$-0.20 - $-0.17	+0.00%	Beat	3	1 0 30d	+73.2%
Jun 30, 2020Jun 20 Reported Aug 11, 2020Reported Aug 11	$-0.51	$-0.24	$-0.24 - $-0.24	-112.50%	Miss	1	No revisions (30d)	+34.6%
Mar 31, 2020Mar 20 Reported May 7, 2020Reported May 7	$-0.41	$-0.41	$-0.41 - $-0.41	+0.00%	Beat	0	No revisions (30d)	+59.8%
Dec 31, 2019Dec 19 Reported Feb 27, 2020Reported Feb 27	$-0.51	$-0.51	-	+0.00%	Beat	-	-	+53.2%
Sep 30, 2019Sep 19 Reported Nov 7, 2019Reported Nov 7	$-0.71	$-0.84	-	+15.48%	Beat	-	-	+34.3%
Jun 30, 2019Jun 19 Reported Aug 8, 2019Reported Aug 8	$-0.78	$-1.02	-	+23.53%	Beat	-	-	+56.7%
Mar 31, 2019Mar 19 Reported May 7, 2019Reported May 7	$-1.02	$-1.07	-	+4.67%	Beat	-	-	+83.2%
Dec 31, 2018Dec 18 Reported Mar 6, 2019Reported Mar 6	$-1.09	$-1.05	-	-3.81%	Miss	-	-	+74.8%
Sep 30, 2018Sep 18 Reported Nov 7, 2018Reported Nov 7	$-1.08	$-1.98	-	+45.45%	Beat	-	-	+87.5%
Jun 30, 2018Jun 18 Reported Aug 3, 2018Reported Aug 3	$-1.80	$-1.98	-	+9.09%	Beat	-	-	+81.7%
Mar 31, 2018Mar 18 Reported May 8, 2018Reported May 8	$-6.06	$-5.76	-	-5.21%	Miss	-	-	+68.8%
Dec 31, 2017Dec 17 Reported Feb 26, 2018Reported Feb 26	$-4.32	N/A	-	+52.00%	Beat	-	-	+80.7%
Sep 30, 2017Sep 17 Reported Nov 9, 2017Reported Nov 9	$-8.64	$-17.28	-	+50.00%	Beat	-	-	-
Jun 30, 2017Jun 17 Reported Aug 9, 2017Reported Aug 9	$-9.82	N/A	-	+57.38%	Beat	-	-	-
Mar 31, 2017Mar 17 Reported May 10, 2017Reported May 10	$-19.44	$-17.28	-	-12.50%	Miss	-	-	-
Dec 31, 2016Dec 16 Reported Mar 15, 2017Reported Mar 15	$-22.44	$-23.04	-	+2.60%	Beat	-	-	-

Key Metrics

Valuation
P/E Ratio	-1.62	EV/EBITDA	N/A
Price/FCF	-1.62x	FCF Yield	-61.61%
Profitability
Profit Margin	0.00%	Operating Margin	-9245.00%
ROE	-94.10%	ROIC	N/A
Financial Health
Debt/Equity	0.00x	Interest Coverage	N/A
Current Ratio	3.30x	Quick Ratio	3.30x
Trading Statistics
Beta	1.42	Avg Volume	571.89K
52-Week High	$3.31	52-Week Low	$0.76

Technical Indicators Dashboard

Moving Averages

SMA 10$1.06

SMA 20$1.16

SMA 50$1.09

SMA 200$1.55

EMA 10$1.05

EMA 20$1.10

EMA 50$1.13

EMA 200$1.50

MACD

Line: -0.04Signal: -0.01Hist: -0.03

ADX

ADX: 22.8+DI: 14.5-DI: 27.8

Aroon & PSAR

Aroon Up12.0

Aroon Down100.0

PSAR$1.10

Bollinger Bands

Upper Band$1.41

Lower Band$0.91

%B Position4358%(Upper)

Band Width0.12

RSI (14-Day)

Neutral

34.0

Momentum Oscillators

Stoch %K4.7

Stoch %D3.7

Williams %R-92.8

ROC (10d)-17.7%

Momentum-0.21

CCI (20d)-126.3

MFI (14d)22.4

Volatility Measures

ATR (14d)$0.07(7.3%)

StdDev (20d)0.13

Hist Vol47.0%(High)

Volume Flow

VWAP$0.97

OBV-41.1M

AD Line-41.1M

CMF (20d)-0.337

Volume Metrics

Avg Vol (20d)479.6K

Vol Ratio0.9x

VWMA (20d)$1.17

Pivot Points

R3$1.14

R2$1.10

R1$1.04

Pivot Point$1.00

S1$0.94

S2$0.90

S3$0.84

Advanced Oscillators

TSI-15.95

Ultimate Osc27.6

KST-28.26

Financial Data

Quarter	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023
Total Revenue	$104,000	$41,000	$243,000	$120,000	$121,000	$109,000	$150,000	$165,000	$163,000	$205,000	$156,000	$141,000
Cost of Revenue	$0	$0	$223,000	$0	$0	$0	$96,000	$0	$0	$0	$103,000	$0
Gross Profit	$104,000	$41,000	$243,000	$120,000	$121,000	$109,000	$150,000	$165,000	$163,000	$205,000	$156,000	$141,000

Operating Expenses	$9.72M	$12.89M	$8.07M	$12.09M	$14.90M	$14.49M	$12.72M	$12.77M	$12.71M	$11.14M	$10.49M	$10.96M
R&D	$5.92M	$6.76M	$5.08M	$8.20M	$11.58M	$10.48M	$9.71M	$9.64M	$9.49M	$8.01M	$7.76M	$8.02M
SG&A	$3.80M	$6.13M	$3.00M	$3.90M	$3.32M	$4.01M	$3.01M	$3.13M	$3.21M	$3.13M	$2.73M	$2.94M
Operating Income	$-9,615,000	$-12,850,000	$-7,827,000	$-11,974,000	$-14,777,000	$-14,382,000	$-12,572,000	$-12,601,000	$-12,545,000	$-10,933,000	$-10,332,000	$-10,820,000

Interest Income	$382,000	$506,000	$612,000	$716,000	$835,000	$941,000	$787,000	$741,000	$805,000	$926,000	$1.01M	$1.07M
Interest Expense	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Income Before Tax	$-9,232,000	$-12,345,000	$-7,216,000	$-11,258,000	$-13,943,000	$-13,434,000	$-11,787,000	$-11,855,000	$-11,778,000	$-10,011,000	$-9,337,000	$-9,731,000
Income Tax Expense	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0

Net Income	$-9,232,000	$-12,345,000	$-7,216,000	$-11,258,000	$-13,943,000	$-13,434,000	$-11,787,000	$-11,855,000	$-11,778,000	$-10,011,000	$-9,337,000	$-9,731,000

EBITDA	$-9,456,000	$-12,723,000	$-8,303,000	$-12,002,000	$-14,850,000	$-14,284,000	$-12,501,000	$-12,517,000	$-12,470,000	$-10,857,000	$-10,447,000	$-11,003,000
EBIT	$-9,614,000	$-12,851,000	$-7,828,000	$-11,974,000	$-14,778,000	$-14,375,000	$-12,574,000	$-12,596,000	$-12,583,000	$-10,937,000	$-10,345,000	$-10,799,000

* Some calculated fields are derived from available data when not provided by source

Related GNG Research

No research available

Be the first to write about CRDF

News

Cardiff Oncology, Inc.(NasdaqCM: CRDF) dropped from S&P Global BMI Index

Cardiff Oncology, Inc. (CRDF) has been removed from the S&P Global BMI Index, as announced on September 20, 2026. This news follows a series of recent stock activities for the company...

marketscreener.com•Sep 20, 2026 10:44 PM ET9/20/26•Bearish

Cardiff Oncology Shares Rise After Upgrade From HC Wainwright

Cardiff Oncology shares rose following an upgrade from HC Wainwright. This indicates a positive outlook from the analyst firm for the company.

Moomoo•Sep 15, 2026 4:32 PM ET9/15/26•Bullish

HC Wainwright Upgrades Cardiff Oncology to Buy From Neutral, Price Target is $9

HC Wainwright has upgraded Cardiff Oncology (CRDF) from Neutral to Buy, setting a price target of $9. This upgrade reflects a positive outlook on the clinical-stage biotechnology company which is advancing cancer...

www.marketscreener.com•Sep 15, 2026 7:00 AM ET9/15/26•Bullish

Cardiff Oncology to Participate in September 2026 Conferences

Cardiff Oncology, Inc. announced its participation in two upcoming conferences in September 2026. Mani Mohindru...

The Manila Times•Sep 2, 2026 6:57 AM ET9/2/26•Somewhat-Bullish

William Blair Downgrades Cardiff Oncology(CRDF.US) to Hold Rating

William Blair has downgraded Cardiff Oncology (CRDF.US) to a Hold rating. This change in rating suggests a revised outlook from the firm regarding the company's stock performance.

Moomoo•Aug 21, 2026 12:12 PM ET8/21/26•Bearish

CRDF Valuation and Fair Value

P/E: -1.6x
P/FCF: -1.6x
P/B: 2.5x

See GNG's fair value

CRDF Profitability: Margins, ROIC and FCF

Gross margin: 100.0%
Operating margin: -9245.0%
Net margin: 0.0%
ROE: -94.1%
FCF margin: -8054.3%
FCF yield: -61.6%

CRDF Competitors

Company	Ticker
Sera Prognostics Inc	SERA
Lixte Biotechnology Holdings Inc	LIXT
Neuraxis, Inc.	NRXS
Kazia Therapeutics Ltd ADR	KZIA
Equillium Inc	EQ
Pelthos Therapeutics Inc.	PTHS
Forian Inc	FORA
Telomir Pharmaceuticals, Inc. Common Stock	TELO

Sector: Healthcare

CRDF Analyst Ratings

Consensus: Hold
Analysts: 6
Strong Buy: 1
Buy: 1
Hold: 4
Sell: 0
Strong Sell: 0

CRDF Bull Case vs Bear Case

Bear case

CRDF's quarterly revenue changed -14.1% year over year.

CRDF Earnings: Beat Rate and Next Report

Beat rate: 5 of 8 quarters (62.5%)
Average surprise: 5.5%
EPS estimate (fiscal period ending Sep 30, 2026): $-0.13
Estimate revisions (30 days, fiscal period ending Sep 30, 2026): 4 up, 0 down

Frequently Asked Questions About CRDF

Does CRDF pay dividends?

Cardiff Oncology Inc (CRDF) does not currently pay a regular dividend.

What is CRDF's market cap?

Cardiff Oncology Inc (CRDF) has a market capitalization of $78.57M with a current stock price of $0.97.

Get full access to GNG Research

Create a free account to access portfolio tracking, advanced tools, and more.

Create Free Account Log In